Trans-scleral contact diode laser cyclophotocoagulation (TCDLC) appears to be a relatively safe and effective method of Eye (2001) 15, 453-457
controlling intraocular pressure in cases of advanced or refractory glaucoma. 1 -7 The diode laser delivers radiation at a wavelength of 810 nm. This wavelength of light usually passes through the sclera with minimal absorption, but is absorbed by the melanin pigment of the ciliary body. Histologically there is damage to the ciliary muscle and epithelium. & -12 The pressure-lowering effect is probably due to a combination of increased uveoscleral flow and damage to the pigmented ciliary epithelium.
Pupillary distortion and scleral damage are rare complications of laser cyclophotocoagulation ? · 13 -15 One case of focal scleral thinning has been reported following Nd:YAG cyclophotocoagulation, 14 but none following TCDLC. There are further reports of 2 cases of scleral perforation developing in areas of thin sclera following TCDLC, 3 , 13 and 1 case of pupillary distortion following TCDLC. 8 We report 3 patients who developed complications after TCDLC: 2 patients without pre-existing scleral thinning developed varying degrees of scleral thinning (one with a staphyloma) and 1 patient suffered pupillary distortion. We also present the histological features following TCDLC in the case complicated by a staphyloma, and we discuss the pathogenesis of the scleral damage and pupillary distortion.
Materials and methods
We reviewed the records of 3 patients in whom there were complications of scleral thinning and pupillary distortion following TCDLC. All operations were performed by the same surgeon using a standard protocol with a diode system (Oculight SLx) to produce the laser energy and deliver it through a c o ntact G-probe attachment of the Iris medical diode laser (Mountain View, CA). The anterior edge of the G-probe footplate was placed at the /' 9 h Fig. 1 . Case I, right eye. Macroscopic pictures: (a) The pupil is white (cataract) and distorted inferiorly, with ectropion uveae. The well-circumscribed staphyloma is at 7 o'clock. (b) and (c) An oblique superior temporal calotte has been removed, exposing a 1800 cO mm wide band of ciliary body destruction, with a white cyclitic membrane extending onto the lens (and a posterior subcapsular cataract). The staphyloma (arrows) is in the pars plana, and there are two white scars in the pars plana/pars plicata.
There is residual brown malignant melanoma (m) posterior to the equator, with a black nodule of melanophages at its anterior edge. Note two white Fuchs' 'adenomas' in ciliary processes above the lens. Histological sections: (d) The lasered ciliary body, limbus and anterior chamber angle (left), centred on the scleral spur (asterisk). Note the destruction and fibrosis of the ciliary epithelium (residual pigment), the ciliary muscle and trabecular meshwork; and anterior synechiae with neovascular membrane on the anterior iris surface. Sections (e)-(h) are from the area of the staphyloma. (e) An overview of the staphyloma just behind (below) the obliterated cilitary body. Note the obliteration of episcleral, scleral and uveal tissue ill the staphyloma (e, g, h). The staphyloma has a thin layer of epithelium, collagen alld cOllsensed vitreous (g), and
there is some epithelial downgrowth into the uvea (h, right). The iris is retracted towards the ciliary body scar, and there is traction on, and distortion of the lens (e). Note the anterior synechiae and pupillary membrane (e). H&E sections. Original magnifications: (d) xl0; (e) x5; (f! x 10; (g) XSO; (h) X2S.
corneoscleral limbus and each laser application was spaced one half-width of the G-probe footplate apart. Histopathological examination was possible in one patient's eye which was enucleated because of continuing discomfort.
Case reports

Case 1
A 46-year-old white woman presented in 1997 with a right posterior pole choroidal malignant melanoma. This was treated with stereotactic radiosurgery with a good response; however, she subsequently developed filamentary keratitis and rubeotic glaucoma. Despite maximum medical treatment the intraocular pressure remained high and she developed bullous keratopathy. TCDLC was performed: 10 applications to the inferior 1800 of the sclera (each application being of 2 W power and 2 s duration). Five audible 'pops' were heard and no scleral thinning was observed at the time of TCDLC application. Two weeks later she had developed a staphyloma inferotemporally in the region of TCDLC application. The bullous keratopathy perSisted and she developed ocular hypotony. The eye remained uncomfortable and she elected to have an enucleation 4 months later.
Macroscopically there was distortion and inferior displacement of the pupil, with ectropion uveae (Fig. la) , and a well-circumscribed 2 mm diameter staphyloma, situated 2 mm from the corneoscleral limbus at 7 o'clock.
Within the eye there was a regressed choroidal malignant melanoma in the temporal quadrant posterior to the equator, and a posterior subcapsular cataract. In the inferior half of the globe the area affected by the cyclodiode was seen as a 5 mm wide band of ciliary body scarring, with an overlying white cyclitic membrane extending onto the posterior surface of the lens. The staphyloma, and two further white scars (1 mm and 1.5 mm), were situated in the pars plana.
Histologically, the laser-treated area included focally pigmented scarring incorporating the iris root, anterior chamber angle, drainage structures and ciliary body (Fig. Id, f) . Traction from this scar had caused pupil and lens distortion (Fig. Ie) . At the site of the staphyloma, there was sharp-edged defect of the episclera, sclera and uvea (Fig. Ie) . The strand of tissue crossing the defect consisted only of a thin layer of conjunctival epithelial cells over strands of collagen, lined internally by condensed vitreous (Fig. Ig) . Some conjunctival epithelial cells had grown downwards a short way over the uvea adjacent to the defect (Fig. Ih) . In addition to the residual choroidal malignant melanoma posterior to the equator, radiation-induced changes were present, including rubeotic glaucoma with ectropion uveae, posterior subcapsular cataract and cystoid macular oedema. 
Case 2
A 52-year-old white woman presented in 1996 with advanced proliferative diabetic retinopathy in the left eye. She had a vitrectomy, membrane peel and endolaser, which was complicated by an intraoperative retinal tear and detachment. In 1997 she had a trabeculectomy with 5-fluorouracil for uncontrolled glaucoma. She developed left rubeotic glaucoma in 1999, which could not be controlled on maximum medical treatment. TCDLC was performed, with 10 applications to the inferior 1800 of the sclera, each application being of 2 W power and 2 s duration. As a result TCDLC was applied to the sclerostomy site. Two weeks later a 2 mm diameter focal area of scleral thinning was observed in the inferotemporal quadrant, corresponding to the previous sclerostomy site (Fig. 2) . 
Case 3
An 85-year-old white man presented in 1996 with a right inferonasal choroidal malignant melanoma, which was treated with stereotactic radiosurgery. In 1999 he developed rubeotic glaucoma which could not be controlled on medical therapy. TCDLC was performed; treatment had to be stopped after only 3 applications (of 2 W power and 2 s duration) because, in spite of the retrobulbar block, the patient complained of pain and kept moving the eye in the direction of the probe. The surgical limbus was difficult to identify because of the presence of arcus senilis. Two audible 'pops' were heard.
Six weeks later he had developed pupillary distortion, and gonioscopy revealed mild peripheral iris damage in the treated region (Fig. 3) .
Discussion
The exact mechanism by which TCDLC causes lowering of intraocular pressure is not known but the target tissue is usually taken to be the pars plicata. Photocoagulation was at the equator (Fig. Ib, c) . It remains pOSSible, however, that a deposit of melanoma (or one of the above pigment lesions) was in and/or adjacent to the damaged tissue and could have been obliterated by the diode laser, leaving no trace to be seen at subsequent histological examination.
In the absence of a local pigment-containing lesion, it is possible that TCDLC treatment in the presence of scleral abnormalities such as thinning could result in perforation or staphyloma. In case 2 the area of focal scleral damage was at the sclerostomy site performed during a previous vitrectomy. In this case the scar may In case 1 we have shown that TCDLC caused disruption of the epithelium of both the pars plicata and (to a lesser degree) the pars plana, with associated destruction of the muscle of the ciliary body, and these histological features are similar to those in previous reports. [8] [9] [10] [11] [12] As far as we are aware this is the first report of in vivo TCDLC-induced scarring of iris root, anterior chamber angle, drainage structures and ciliary body (Fig. Id, e) with traction from this scar causing pupil and lens distortion (Fig. Ie) . This is also the first report of the histopathological features of a staphyloma following TCDLC.
It appears that there may be several mechanisms, acting alone or in combination, whereby abnormal tissue damage can result from TCDLC treatment. Such tissue damage, with resulting iris and pupillary distortion and/ or staphyloma, may be avoided if we pay attention to following: 1. Avoid or treat cautiously areas of abnormally thin or scarred sclera and pigmented or vascular lesions of the conjunctiva, episclera, sclera and ciliary body. 2. Inspect and wipe the tip of the G-probe between applications. 3. Transilluminate the eye to identify the position of the ciliary body. In cases where transillumination is not possible, ultrasound biomicroscopy or axial length measurements can be used as a guide to the location of the ciliary body.
